Target intelligence / Profile preview

ADAM metallopeptidase domain 20 pseudogene 1 (ADAM20P1)

Target
ADAM20P1
Molecular classification
Pseudogene
01

Overview

ADAM metallopeptidase domain 20 pseudogene 1 (ADAM20P1) is classified as a pseudogene in the human genome and has no known protein-coding or enzymatic function[1][3]. Pseudogenes are gene-like DNA sequences that have lost their protein-coding ability due to disabling mutations. ADAM20P1 is a member of the ADAM gene family, which typically encodes multidomain proteins involved in processes such as cell adhesion, migration, and proteolysis[2][4]. However, as a pseudogene, ADAM20P1 does not encode a functional protein and does not participate in any known biological processes or serve as a therapeutic target. There are no known drugs or disease associations related to ADAM20P1. The gene is listed in genetic databases (such as NCBI Gene: 317760 and Ensembl: ENSG00000290783) solely for reference, and its main scientific relevance is in genomics or evolutionary studies rather than protein function or drug targeting[1][3].

Other names
ADAM20PADAM20 pseudogeneENSG00000290783

Beyond the preview

Go deeper on ADAM metallopeptidase domain 20 pseudogene 1 (ADAM20P1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ADAM metallopeptidase domain 20 pseudogene 1 (ADAM20P1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call